Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Lagergren

Showing results (1-10 of 435) with videos related to

Pageof 44
Sort By:
Epidemiology (Cambridge, Mass.)|October 28, 2016
Using the Lorenz Curve to Assess the Feasibility of Targeted Screening for Esophageal AdenocarcinomaShao-Hua Xie, Jesper Lagergren, Jesper Lagergren
The British Journal of Surgery|October 8, 2021
Author response to: Survival after antireflux surgery versus medication in patients with reflux oesophagitis or Barrett's oesophagus: multinational cohort studyJesper Lagergren
Gut|May 24, 2007
Body measures in relation to gastro-oesophageal refluxJesper Lagergren
Gastrointestinal Endoscopy|November 6, 2008
Any role for endoscopy screening or surveillance for esophageal adenocarcinoma among persons with GERD?Jesper Lagergren
Journal of the National Cancer Institute|May 11, 2026
Response to Drs Zhe Zhang and Hongbo WuJesper Lagergren
Nature Reviews. Gastroenterology & Hepatology|June 7, 2011
Influence of obesity on the risk of esophageal disordersJesper Lagergren
JAMA Oncology|March 29, 2019
Notice of Retraction. Maret-Ouda et al. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries. JAMA Oncol. 2018;4(11):1576-1582Jesper Lagergren
Lakartidningen|October 26, 2007
[Esophageal cancer surgery should be centralized. Big surgical volume benefits the patients]Jesper Lagergren
Best Practice & Research. Clinical Gastroenterology|September 26, 2006
Etiology and risk factors for oesophageal adenocarcinoma: possibilities for chemoprophylaxis?Jesper Lagergren
Nature Reviews. Gastroenterology & Hepatology|December 3, 2014
Oesophageal cancer in 2014: Advances in curatively intended treatmentJesper Lagergren
Pageof 44

Showing results (1-10 of 435) with videos related to

Sort By:
Pageof 44
Epidemiology (Cambridge, Mass.)|October 28, 2016
Using the Lorenz Curve to Assess the Feasibility of Targeted Screening for Esophageal AdenocarcinomaShao-Hua Xie, Jesper Lagergren, Jesper Lagergren
The British Journal of Surgery|October 8, 2021
Author response to: Survival after antireflux surgery versus medication in patients with reflux oesophagitis or Barrett's oesophagus: multinational cohort studyJesper Lagergren
Gut|May 24, 2007
Body measures in relation to gastro-oesophageal refluxJesper Lagergren
Gastrointestinal Endoscopy|November 6, 2008
Any role for endoscopy screening or surveillance for esophageal adenocarcinoma among persons with GERD?Jesper Lagergren
Journal of the National Cancer Institute|May 11, 2026
Response to Drs Zhe Zhang and Hongbo WuJesper Lagergren
Nature Reviews. Gastroenterology & Hepatology|June 7, 2011
Influence of obesity on the risk of esophageal disordersJesper Lagergren
JAMA Oncology|March 29, 2019
Notice of Retraction. Maret-Ouda et al. Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries. JAMA Oncol. 2018;4(11):1576-1582Jesper Lagergren
Lakartidningen|October 26, 2007
[Esophageal cancer surgery should be centralized. Big surgical volume benefits the patients]Jesper Lagergren
Best Practice & Research. Clinical Gastroenterology|September 26, 2006
Etiology and risk factors for oesophageal adenocarcinoma: possibilities for chemoprophylaxis?Jesper Lagergren
Nature Reviews. Gastroenterology & Hepatology|December 3, 2014
Oesophageal cancer in 2014: Advances in curatively intended treatmentJesper Lagergren
Pageof 44